PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 16, 2026Expert Opinion on Drug Metabolism & Toxicology0 citations

Post-marketing pharmacovigilance of tedizolid: emerging safety signals

View Full Paper
HYHaiping YaoChina Three Gorges UniversityGGGuoping GanZWZhu WangChina Three Gorges University

Key Points

  • To evaluate emerging safety signals associated with tedizolid and understand their clinical significance.
  • Analysis of post-marketing pharmacovigilance data on tedizolid.
  • Identification of hematologic, hepatic, neuropsychiatric, and gastrointestinal risks.
  • Confirmed hematologic risks related to tedizolid use.
  • Identified additional potential hepatic, neuropsychiatric, and gastrointestinal safety signals.

Abstract

Post-marketing data confirm TED's hematologic risks and reveal additional potential hepatic, neuropsychiatric, and gastrointestinal signals. These findings merit further evaluation and prospective studies to clarify clinical significance, establish causality, and optimize monitoring strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yao et al. (2026) studied this question.

synapsesocial.com/papers/69e07d3c2f7e8953b7cbe48chttps://doi.org/10.1080/17425255.2026.2660710
Ask AI
Helpful
Bookmark
Share
View Full Paper